OSN
INDIAN WELLS, Calif. — Administering bevacizumab to patients with neovascular glaucoma before they undergo surgery appears effective for improving the reduction in IOP, according to a surgeon speaking here.
At the annual meeting of the American Society of Retina Specialists, Rohit Ross Lakhanpal, MD, presented the results of a retrospective study of 112 consecutive eyes treated for neovascular glaucoma. All eyes underwent pars plana vitrectomy, laser photocoagulation and Ahmed glaucoma valve implantation (New World Medical).